๐ฏ Endoscopy Center · Apgujeong Hana Clinic
Stomach Cancer Screening Seoul
English-supported gastric cancer screening in Gangnam using gastroscopy to inspect the stomach lining, identify suspicious or precancerous changes and arrange targeted biopsy and follow-up when indicated.
โ
High-definition stomach examination
โ
Targeted biopsy when indicated
โ
English result guidance
Early-Detection Mapping
Screening pathway
01
Risk & History Review
Age, family history, H. pylori, previous findings and symptoms.
02
Gastroscopy
Systematic inspection of the stomach lining and upper digestive tract.
03
Targeted Biopsy
Small tissue samples when an area requires microscopic assessment.
04
Result & Follow-Up
Normal screening, treatment, surveillance or referral according to findings.
STOMACH LINING
Direct visual examination
PRECURSOR CHANGE
Atrophy, metaplasia or dysplasia
BIOPSY
Microscopic confirmation
FOLLOW-UP
Individual interval and plan
Screening reduces uncertainty but cannot guarantee that every cancer or precancerous lesion will be detected. Symptoms always require medical assessment even after a previous normal test.
๐ฐ๐ท
Korea Screening Context
Adults aged 40 and over are included in Korea's national stomach-screening framework every two years.
๐น
Gastroscopy-Based Review
The camera directly examines the oesophagus, stomach and duodenum.
๐ฌ
Biopsy When Needed
Suspicious or clinically relevant areas can be sampled for pathology.
โ
English Preparation Guidance
โ
Gastric Mucosal Examination
โ
Biopsy & Pathology Coordination
โ
Apgujeong · Gangnam
Screening For Early Gastric Change
Screening looks for stomach cancer before symptoms appear.
Stomach cancer begins in cells of the stomach lining. Early disease may cause no clear symptoms, so organised screening is used in higher-incidence settings such as Korea.
Gastroscopy allows the doctor to inspect the lining directly, document subtle changes and take a biopsy from an area that requires microscopic diagnosis.
A normal examination lowers concern at that point in time but does not permanently remove future risk. The next screening or surveillance interval depends on age, previous findings and individual risk.
01
๐
Systematic Inspection
The stomach is examined by anatomical area rather than by symptoms alone.
02
๐
Surface Pattern Review
Colour, contour, ulcers, polyps, bleeding and irregular tissue are assessed.
03
๐ฌ
Pathology Confirmation
Biopsy may distinguish inflammation, precancerous change and cancer.
Korea Screening Context
Korea's national program lists stomach screening from age 40.
National Cancer Screening Program reference
The National Cancer Center Korea lists adults aged 40 and over for stomach screening every two years using upper gastrointestinal imaging or gastrointestinal endoscopy. This page describes the clinic's medical service and does not guarantee public-program eligibility, insurance coverage or a specific screening interval for every patient.
๐๏ธ
Routine Screening
Testing performed in a person without alarm symptoms, based on age, national guidance or individual risk. The purpose is early detection.
๐ฉ
Diagnostic Gastroscopy
Testing performed because symptoms, anemia, bleeding, weight loss, vomiting, swallowing difficulty or another abnormal result needs investigation.
Who May Need Individual Review?
Age is important, but screening decisions also consider gastric cancer risk.
๐
Age 40 Or Older In Korea
Korea's organised stomach-screening program begins at age 40, although individual advice may differ.
๐ฆ
H. pylori Infection
Chronic H. pylori infection is a major gastric cancer risk factor and may cause atrophic gastritis.
๐จ๐ฉ๐ง
Family History
A first-degree relative with stomach cancer or a hereditary cancer syndrome may change risk assessment.
๐งฌ
Atrophy Or Intestinal Metaplasia
Previous gastric atrophy, intestinal metaplasia, dysplasia or adenomatous polyps may require surveillance.
๐ฌ
Smoking & Lifestyle Factors
Tobacco use and diets high in salted, smoked or poorly preserved foods can contribute to risk.
๐
Previous Stomach Findings
Past ulcers, gastric surgery, polyps, abnormal biopsy or previous gastric cancer require personalised follow-up.
What Gastroscopy Can Assess
The examination evaluates cancer and many non-cancerous stomach conditions.
Early Gastric Lesions
Small, flat, depressed or colour-changing abnormalities may be assessed and biopsied.
Precancerous Change
Biopsy can assess atrophic gastritis, intestinal metaplasia and dysplasia when indicated.
H. pylori-Related Disease
Inflammation, ulcers and H. pylori testing may be considered as part of the evaluation.
Ulcers & Erosions
Open sores, inflammation and bleeding sources can be documented and sampled if necessary.
Polyps & Raised Lesions
Polyps or masses may require biopsy, removal planning, surveillance or referral.
Bleeding Or Anemia Sources
Visible bleeding, fragile tissue and other upper-GI causes of anemia may be investigated.
Appearance alone may not provide the final diagnosis
Gastritis, ulcers, dysplasia and early cancer can overlap visually. Targeted tissue sampling and pathology may be required before the result is confirmed.
Before Screening Gastroscopy
Safe, clear examination depends on fasting and medicine review.
Use the clinic's written instructions for your appointment. Exact fasting and medication directions vary with procedure time, sedation, diabetes, GLP-1 medicine use and other health conditions.
01
Share Medical History
Report heart, lung, kidney or liver disease, sleep apnoea, pregnancy, allergies and previous sedation reactions.
02
Review Medicines
Discuss blood thinners, insulin, diabetes tablets, GLP-1 medicines, iron, supplements and stomach medicines.
03
Follow Fasting Instructions
The stomach must be empty enough for safe sedation and clear inspection. Do not improvise the fasting schedule.
04
Arrange Sedation Recovery
When intravenous sedation is planned, arrange an escort or transport and follow post-sedation restrictions.
Do not independently stop prescribed medicines
Blood thinners and diabetes medicines need individual instructions. Stopping them without medical advice can create a different and sometimes serious risk.
Screening-Day Pathway
From risk review to a documented follow-up plan.
๐
Step 1
Pre-Procedure Check
Confirm fasting, medicines, allergies, previous results and sedation suitability.
๐น
Step 2
Gastroscopy
A thin flexible camera examines the oesophagus, stomach and duodenum.
๐ฏ
Step 3
Targeted Inspection
Suspicious or high-risk areas are photographed and assessed carefully.
๐ฌ
Step 4
Biopsy If Indicated
Small samples are taken through the endoscope and sent for pathology.
๐ฉบ
Step 5
Results & Plan
Findings guide routine rescreening, treatment, surveillance, repeat testing or referral.
Biopsy, H. pylori & Pathology
Microscopic testing can clarify what the camera cannot confirm.
From stomach image to confirmed diagnosis
A suspected area is documented, sampled and matched with a pathology report before the final clinical plan is made.
๐
Target
๐งช
Sample
๐ฌ
Pathology
๐
Plan
๐ฆ
H. pylori Testing
Biopsy-based testing may be used when clinically appropriate, although non-invasive tests are also available.
๐ฅ
Gastritis & Atrophy
Microscopy can describe inflammation and atrophic changes in the stomach lining.
๐งฌ
Intestinal Metaplasia
Specialised cell change may influence eradication treatment and future surveillance.
โ ๏ธ
Dysplasia
Precancerous abnormal cells may require expert review, repeat mapping or therapeutic endoscopy.
๐๏ธ
Cancer Confirmation
A tissue diagnosis is generally required before cancer treatment planning.
๐
Clinical Correlation
Pathology is interpreted together with the endoscopy image, location and medical history.
Understanding Results
Not every abnormal result is cancer, and every result needs the right next step.
Path 1
โ
No Significant Abnormality
Continue age- and risk-appropriate screening according to the recommended interval.
Path 2
๐ฆ
H. pylori Or Inflammation
Treatment and confirmation of eradication may be recommended according to the test result.
Path 3
๐งฌ
Precancerous Change
Atrophy, metaplasia or dysplasia may require mapped surveillance or specialist management.
Path 4
๐ฅ
Suspicious Or Confirmed Cancer
Prompt referral for staging and multidisciplinary treatment planning is arranged.
Visual results may be discussed before pathology is complete
The endoscopist can explain what was seen after recovery. Biopsy results take additional laboratory processing time and may change the final diagnosis or follow-up interval.
Benefits, Limits & Safety
Screening can support early detection, but it is not a perfect test.
๐ Important Limitations
โ
A normal result does not guarantee that cancer is absent or will not develop later.
โ
Small or subtle lesions can occasionally be missed.
โ
Abnormal-looking tissue may prove non-cancerous after biopsy.
โ
A suspicious finding may require repeat endoscopy, additional biopsy or referral.
โ
New symptoms need assessment even after a recent normal screening test.
โ ๏ธ Gastroscopy Risks
!
Reaction to sedation, including breathing, heart-rate or blood-pressure problems.
!
Bleeding, especially after biopsy or treatment.
!
Perforation or tear of the upper digestive tract.
!
Aspiration of stomach contents into the lungs.
!
Dental injury, infection or need for additional care.
Do Not Wait For Routine Screening
Alarm symptoms require prompt diagnostic assessment.
โ๏ธ
Unexplained Weight Loss
Unexpected or progressive weight loss needs medical evaluation rather than waiting for a routine test date.
๐ฝ๏ธ
Persistent Early Fullness
Ongoing inability to finish meals, loss of appetite or progressive upper abdominal discomfort should be reviewed.
๐คฎ
Repeated Vomiting
Persistent vomiting, inability to keep food down or vomiting blood requires prompt assessment.
๐ฉธ
Black Stool Or Bleeding
Black tar-like stool, coffee-ground vomit or visible blood can indicate upper-GI bleeding.
๐ฎ๐จ
Anemia Or Severe Fatigue
Unexplained iron-deficiency anemia, breathlessness or marked weakness may reflect hidden bleeding.
๐ฅฃ
Swallowing Difficulty
Food sticking, painful swallowing or progressive difficulty eating needs diagnostic evaluation.
Apgujeong, Gangnam
Stomach cancer screening guidance in English.
Apgujeong Hana Clinic supports expats, residents and international patients who need gastric screening, symptom evaluation, biopsy coordination and follow-up in Seoul.
๐
328 Apgujeong-ro, Gangnam-gu, Seoul, KFC Building 3F
๐
Monday–Friday 09:00–19:00
๐๏ธ
Saturday 09:00–13:00
๐
02) 3443-7550
โ๏ธ
Internal-Medicine Evaluation
English-supported review of screening history, symptoms, gastric cancer risks, medicines, sedation considerations and the appropriate follow-up pathway.
FAQ
Stomach cancer screening questions, answered.
Screening intervals, biopsy decisions, sedation and preparation must be personalised. Confirm the exact instructions for your appointment.
Stomach cancer screening is testing performed before symptoms develop to look for early gastric cancer or changes that may need biopsy and follow-up. In Korea, gastroscopy is one of the established screening methods.
The Korean National Cancer Screening Program lists adults aged 40 and over for stomach screening every two years using upper gastrointestinal imaging or gastrointestinal endoscopy. Eligibility, insurance coverage and appointment arrangements should be confirmed separately.
Gastroscopy is the examination method. It may be used for routine screening, for follow-up of a previous finding or as a diagnostic test when symptoms are present.
Gastroscopy allows direct inspection of the stomach lining and targeted biopsy of suspicious areas. No test guarantees detection, and image quality, preparation, lesion characteristics and pathology all affect the final assessment.
A biopsy may be taken when the doctor sees an abnormal area or when tissue sampling is clinically indicated. Not every screening gastroscopy requires biopsy.
H. pylori assessment may be discussed because chronic infection is an important stomach cancer risk factor. Testing may be biopsy-based or non-invasive depending on the clinical situation and medicine use.
Korea's national program lists a two-year interval for adults aged 40 and over. A different interval may be recommended for previous polyps, atrophic gastritis, intestinal metaplasia, family history, prior cancer or other individual risks.
No. Persistent upper abdominal pain, unexplained weight loss, repeated vomiting, swallowing difficulty, anemia, vomiting blood or black stool requires prompt diagnostic assessment rather than waiting for a routine screening date.
Sedation may be considered after reviewing health history, medicines, fasting, breathing risk and transport arrangements. Sedation is not suitable or necessary for every patient.
Apgujeong Hana Clinic provides English support for booking, preparation, medicine review, gastroscopy guidance, biopsy explanation and follow-up planning.
Related Endoscopy Services
Choose the examination and follow-up pathway that fits the clinical question.
English Endoscopy Support
Plan stomach screening with clear English guidance.
Contact Apgujeong Hana Clinic to review age, previous endoscopy results, family history, H. pylori, symptoms, medicines and the most appropriate examination pathway.